Conditions That Can Be Treated With Psychedelics
Are your clients facing challenges with mental or physical health issues?
Have they been pursuing healing through conventional medical treatments without relief?
Depression
Anxiety
Obsessive Compulsive Disorder
End of Life Anxiety
Eating Disorders
Addiction
Migraines
Fibromyalgia
Long Covid
PTSD…
Currently, researchers are striving to understand how psychedelics can assist those overlooked by our conventional system. Join us as we explore how we, as therapists, can support our most vulnerable clients in navigating the health and wellness industry, addressing stigma and biases within these systems, and making informed decisions to ensure their well-being and safety.
Supporting Vulnerable Clients: Exploring Psychedelics in Treatment
As therapists, we often act as the first point of contact for clients seeking relief from complex mental and physical health challenges. For many individuals, conventional medical treatments offer limited results, which can be discouraging and even further traumatizing. Depression, anxiety, obsessive-compulsive disorder (OCD), end-of-life anxiety, eating disorders, addiction, migraines, fibromyalgia, Long-COVID, and PTSD are just a few conditions that can significantly impact daily life, leaving clients in search of alternative pathways to find relief healing.
In recent years, psychedelics have emerged as a promising area of research for addressing conditions that traditional therapies have struggled to treat. Studies on substances such as psilocybin, MDMA, ketamine, and ayahuasca indicate potential therapeutic benefits—particularly for clients who feel overlooked or misunderstood by the conventional healthcare system.
Our role as therapists in this evolving field is pivotal. As we explore the use of psychedelics in therapy, we must recognize the importance of a harm reduction approach, ensuring that clients are educated, supported, and safe throughout the process. We can assist our clients in navigating challenging situations within the health and wellness industry, which often feels fragmented, biased, and overwhelming. As professionals, we must proactively identify and address the stigma and biases present in current systems. These biases can limit our clients' access to alternative treatments and exacerbate their situation struggles.
In the supervision group on March 4, 2025, we will explore the conditions most commonly treated with psychedelics, from mental health challenges to chronic physical ailments. We will discuss how to approach these topics with clients, the latest research on psychedelic-assisted therapies, and how we can best advocate for those who feel unseen or unheard. By equipping ourselves with knowledge and understanding, we can create a space where our clients feel empowered to make informed decisions, prioritizing their well-being and safety. I look forward to coming together as a community of therapists to explore this exciting and transformative area of therapy. Together, we can enhance our skills and provide compassionate care to our most vulnerable clients.
Upcoming Group
March 4, 2025, 9 am-12 pm
Delivered Online via ZOOM
The cost is $250 for 3 hours of group supervision. Groups are limited to 8 participants.
Please send all inquiries to kelly@kellystonetherapy.com
*When booking through JaneApp, please make sure to choose the correct date for the event you wish to attend.
